For in vivo validation, AGK2 or aspirin treatment exhibited comparable efficacy with anti–LAG-3 mAb in suppressing tumor growth, and we detected no statistical significance between these 3 therapeutic strategies (Supplemental Figure 5, H and I). This evidence concerns the gene LAG3 and neoplasm.